<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04885803</url>
  </required_header>
  <id_info>
    <org_study_id>Vitamin D Absorbance Study</org_study_id>
    <nct_id>NCT04885803</nct_id>
  </id_info>
  <brief_title>Vitamin D Absorbance Study - Clinical Trial of the Absorbance of Nano Liquid D3</brief_title>
  <acronym>ViDAS</acronym>
  <official_title>Vitamin D Absorbance Study - A Decentralized, Randomized, Double-blind, Placebo-controlled Clinical Trial of the Pharmacokinetics of Vitamin D3 Absorption From Softgel Supplements Compared to Nano Liquid D3 Supplements in Humans.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inspired Life Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inspired Life Medical, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitamin D is a commonly available essential prohormone humans need to regulate blood calcium&#xD;
      and has recently emerged as potentially helpful in combating severe COVID-19. Despite its&#xD;
      importance, some studies estimate as much as 40% of the US population is deficient in vitamin&#xD;
      D. Most available vitamin D supplements have little absorption data and are nearly all&#xD;
      softgels or capsules. This clinical trial is designed as a preliminary pharmacokinetics study&#xD;
      to assess the absorbance of a nano liquid D3 supplement that can be taken as an oral spray&#xD;
      once daily. Preliminary evidence suggests that this nano liquid D3 may be absorbed more&#xD;
      readily than commercially available softgel dosage forms of D3. This randomized,&#xD;
      double-blind, placebo-controlled trial will compare nano liquid D3 to commonly available D3&#xD;
      oral softgels and a placebo control group over the course of a thirty-one (31) day study&#xD;
      period.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 26, 2021</start_date>
  <completion_date type="Actual">July 30, 2021</completion_date>
  <primary_completion_date type="Actual">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>Full blinding protocols employed to mask all participants, all those engaging with participants, and the PI for the duration of the study period.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in 25(OH)D Blood Serum Levels</measure>
    <time_frame>31 days</time_frame>
    <description>Change in 25(OH)D blood serum levels in the test group taking 5,000 IU of Nano Liquid D3 daily after supplementation compared to the placebo control during the same time frame</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">114</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>Nano Liquid D3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm receiving Nano Liquid Vitamin D3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Softgel D3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group receiving Softgel Vitamin D3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Liquid mixture, identical in process, taste, smell, and appearance to Nano Liquid D3, but containing no active ingredient (no Vitamin D3)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Softgel Vitamin D3</intervention_name>
    <description>5000IU vitamin D3 taken as single oral softgel once daily for 30 days</description>
    <arm_group_label>Softgel D3</arm_group_label>
    <other_name>Cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nano Liquid Vitamin D3</intervention_name>
    <description>5000IU vitamin D3 taken as liquid oral spray once daily for 30 days</description>
    <arm_group_label>Nano Liquid D3</arm_group_label>
    <other_name>Cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>25(OH)D Blood Serum Test</intervention_name>
    <description>A sample of blood is drawn off and processed for 25(OH)D levels at baseline, after 15 days of supplementation, and after 30 days of supplementation</description>
    <arm_group_label>Nano Liquid D3</arm_group_label>
    <arm_group_label>Placebo Control</arm_group_label>
    <arm_group_label>Softgel D3</arm_group_label>
    <other_name>Vitamin D Blood Test</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo Control</intervention_name>
    <description>Liquid oral spray once daily for 30 days. Solution identical in smell, taste, color, and production process to Nano Liquid D3, but containing no Vitamin D3.</description>
    <arm_group_label>Placebo Control</arm_group_label>
    <other_name>Nano Liquid Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults, ages 18-70 years old&#xD;
&#xD;
          -  Either male or female&#xD;
&#xD;
          -  Taking less than 2,000 IU of vitamin D daily as a supplement during the 30 days before&#xD;
             starting the study&#xD;
&#xD;
          -  Ability to swallow a pill of typical size or a liquid less than 1 mL daily for 30 days&#xD;
&#xD;
          -  Ability to speak, read, and understand English&#xD;
&#xD;
          -  Access to smart phone or smart device with internet access for study-related&#xD;
             communications&#xD;
&#xD;
          -  Ability to do 3 at-home vitamin D finger prick blood tests on 3 separate days. The&#xD;
             kits and supplies will be given to you.&#xD;
&#xD;
          -  Ability to drop off finished blood tests at a UPS store or UPS drop box, or schedule a&#xD;
             UPS pickup at your home, on each of the same days as you do the blood tests&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Females who are pregnant&#xD;
&#xD;
          -  Taking, on average, more than 2,000 IU of vitamin D daily within 30 days before the&#xD;
             study&#xD;
&#xD;
          -  Currently have COVID-19 infection&#xD;
&#xD;
          -  History of COVID-19 infection or positive COVID-19 test in last 60 days&#xD;
&#xD;
          -  People with a diagnosis of Cystic Fibrosis&#xD;
&#xD;
          -  People with a diagnosis of Crohn's Disease&#xD;
&#xD;
          -  People diagnosed with Celiac Disease&#xD;
&#xD;
          -  People with known diagnosis or history of any kidney related disease Including, but&#xD;
             not limited to: Chronic kidney disease; End stage renal disease; Polycystic kidney&#xD;
             disease; Lupus nephritis; Kidney cancer, Alport syndrome; Amyloidosis; Goodpasture&#xD;
             syndrome; and Wegener's granulomatosis&#xD;
&#xD;
          -  People with known diagnosis or history of any liver related disease Including, but not&#xD;
             limited to: Hepatitis A; Hepatitis B; Hepatitis C; Fatty liver disease; Cirrhosis of&#xD;
             the liver; Liver cancer; Hemochromatosis; Wilson disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Melanie Schroeder, PharmD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inspired Life Medical, Inc.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Noah B Goodson, PhD</last_name>
    <role>Study Director</role>
    <affiliation>The Scope Method, LLC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Inspired Life Medical Office</name>
      <address>
        <city>Le Sueur</city>
        <state>Minnesota</state>
        <zip>56058</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>May 6, 2021</study_first_submitted>
  <study_first_submitted_qc>May 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2021</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

